e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Surgery and lung cancer: results and complications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pneumonectomy for lung cancer after induction chemotherapy alone: Is the risk really higher?
Milan Savic (Belgrade, Republic of Serbia), Milan Savic, Dragan Subotic, Nikola Atanasijadis, Dejan Moskovljevic, Milan Gajic, Vladimir Milenkovic, Marko Popovic
Source:
International Congress 2015 – Surgery and lung cancer: results and complications
Session:
Surgery and lung cancer: results and complications
Session type:
Thematic Poster Session
Number:
2516
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Milan Savic (Belgrade, Republic of Serbia), Milan Savic, Dragan Subotic, Nikola Atanasijadis, Dejan Moskovljevic, Milan Gajic, Vladimir Milenkovic, Marko Popovic. Pneumonectomy for lung cancer after induction chemotherapy alone: Is the risk really higher?. Eur Respir J 2015; 46: Suppl. 59, 2516
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Surgical treatmment non-small cell lung cancer in the elderly patients
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009
Smoking at the time of curative-intent lung cancer surgery dramatically influences peri-operative complications
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Immunosuppressive treatment is not a predictor of mortality after surgical lung biopsy for interstitial lung disease
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Surgical treatment of locally recurrent lung cancer
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007
Surgical treatment of nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170
Year: 2001
Risk factors for prolonged postoperative air leak-a retrospective analysis of 853 partial lung resections for non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Sleeve lung resection for non-small cell lung cancer after induction therapy: A safe method
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Source: Eur Respir J 2010; 35: 202-215
Year: 2010
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Lobectomy at patients with lung cancer and a chronic obstructive pulmonary disease as analogue of lung volume reduction surgery in COPD patients: To do or not to do?
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept